0

    526075

    VINRKLB

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    REKVINA LABORATORIES LTD. Share Price Today

    Investment Returns

    Over 1 Month -7.23% Over 3 Months 1.86% Over 6 Months 401.41% Over 1 Year 0.00%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    REKVINA LABORATORIES LTD. fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 20.70
    • P/E Ratio (TTM) -83.33
    • Beta -0.29
    • Book Value / share -2.03
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) -0.06
    info icon alternate text

    REKVINA LABORATORIES LTD. Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 0.72
    Operating Expense 0.78
    Net Profit -0.06
    Net Profit Margin (%) -8.33
    Earnings Per Share (EPS) -0.10
    EBITDA -0.06
    Effective Tax Rate (%) 0.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 0.35
    Operating Expense 0.47
    Net Profit -0.12
    Net Profit Margin (%) -34.28
    Earnings Per Share (EPS) -0.21
    EBITDA -0.12
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 0.20
    Operating Expense 0.23
    Net Profit -0.03
    Net Profit Margin (%) -15.00
    Earnings Per Share (EPS) 0.06
    EBITDA -0.03
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.04
    Net Profit -0.04
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.05
    EBITDA -0.04
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.04
    Net Profit -0.04
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.07
    EBITDA -0.04
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 1.27
    Operating Expense 1.52
    Net Profit -0.25
    Net Profit Margin (%) -19.68
    Earnings Per Share (EPS) -0.42
    EBITDA -0.25
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.14
    Net Profit -0.14
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.23
    EBITDA -0.14
    Effective Tax Rate (%) 0.00
    Particulars MAR 2024 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.02
    Net Profit -0.02
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.03
    EBITDA -0.02
    Effective Tax Rate (%) 0.00
    Particulars MAR 2023 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.00
    Net Profit 0.00
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.00
    EBITDA 0.00
    Effective Tax Rate (%) 0.00
    Particulars MAR 2022 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.08
    Net Profit -0.08
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.13
    EBITDA -0.08
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share -0.55
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin 0.00
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share -0.32
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin 0.00
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 0.02
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 4.00
    EBITDA Margin 0.00
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 0.02
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin 0.00
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 0.15
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin 0.00
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.02
    Total Assets 0.03
    Total Liabilities 0.03
    Total Equity -0.33
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -421.84
    Return on Capital (%) 160.73
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.00
    Total Assets 0.00
    Total Liabilities 0.00
    Total Equity -0.19
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -172.63
    Return on Capital (%) 10.53
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.00
    Total Assets 0.20
    Total Liabilities 0.20
    Total Equity 0.01
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -0.34
    Return on Capital (%) -0.74
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.00
    Total Assets 0.19
    Total Liabilities 0.19
    Total Equity 0.01
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -41.02
    Return on Capital (%) -566.88
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.00
    Total Assets 0.24
    Total Liabilities 0.24
    Total Equity 0.09
    Share Outstanding 0
    Price to Book Ratio 26.47
    Return on Assets (%) -26.45
    Return on Capital (%) -69.18
    Particulars MAR 2025 (Values in Cr)
    Net Income -0.13
    Cash from Operations -0.19
    Cash from Investing 0.00
    Cash from Financing 0.20
    Net change in Cash 0.01
    Free Cash Flow -0.19
    Particulars MAR 2024 (Values in Cr)
    Net Income -0.01
    Cash from Operations 0.00
    Cash from Investing 0.00
    Cash from Financing 0.00
    Net change in Cash 0.00
    Free Cash Flow 0.00
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.00
    Cash from Operations 0.00
    Cash from Investing 0.00
    Cash from Financing 0.00
    Net change in Cash 0.00
    Free Cash Flow 0.00
    Particulars MAR 2022 (Values in Cr)
    Net Income -0.07
    Cash from Operations -0.03
    Cash from Investing 0.04
    Cash from Financing 0.00
    Net change in Cash 0.00
    Free Cash Flow -0.03
    Particulars MAR 2021 (Values in Cr)
    Net Income -0.06
    Cash from Operations 0.00
    Cash from Investing 0.00
    Cash from Financing 0.00
    Net change in Cash 0.00
    Free Cash Flow 0.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 31.51 13.02 1.52 241.47 23.12 38.85
    BLISS GVS PHARMA LTD. 492.50 39.98 4.37 5223.27 118.35 495.00
    CIPLA LTD. 1440.30 30.57 3.37 116353.96 1165.55 1672.20
    FERMENTA BIOTECH LTD. 365.50 16.12 2.64 1075.70 256.40 399.00
    GLAXOSMITHKLINE PHARMACEUTICAL 2358.85 41.53 17.62 39960.34 2088.00 3500.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 31.51 22.03 4.05 241.47 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 538.05 24.12 4.20 1555.54 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8382.65 109.48 24.01 20956.63 7630.00 9850.00
    BLISS GVS PHARMA LTD. 492.50 53.13 4.52 5223.27 118.35 495.00

    REKVINA LABORATORIES LTD. shareholding pattern

    Holding
    58.7%
    41.29%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    REKVINA LABORATORIES LTD. Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    34.30 -2.00 redarrow
    red-green-graph indicator
    14 Bearish
    2 Bullish
    • 5 Days 36.00
    • 26 Days 38.50
    • 10 Days 37.00
    • 50 Days 37.70
    • 12 Days 37.40
    • 100 Days 32.50
    • 20 Days 38.20
    • 200 Days 24.50
    35.98 PIVOT
    First Support 35.98 First Resistance 35.98 Second Support 35.98 Second Resistance 35.98 Third Support 35.98 Third Resistance 35.98
    RSI 35.75 ADX 11.52 MACD -0.95 Williams % R -97.07 Commodity Channel Index (CCI) -116.29
    Date 2026-06-25 Week 1981.00 Same Day 3723.00 Month 1805.00
    1 Year -0.31 3 Year -0.41
    Over 1 Month
    -7.23% down
    Over 1 Year
    0.00% down
    Over 3 Months
    1.86% down
    Over 3 Years
    0.00% down
    Over 6 Months
    401.41% down
    Over 5 Years
    58.04% down

    REKVINA LABORATORIES LTD. Corporate Actions

    Ex-Date Old FV NEW FV Record Date
    30 Apr 2014 10.0 5.0 02 May 2014

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Rekvina Labs Ltd?

    Answer Field

    Rekvina Labs Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 34.30 as on Jun 30 2026 10:15 AM.

    What is the Market Cap of Rekvina Labs Ltd Share?

    Answer Field

    The market cap of Rekvina Labs Ltd for NSE ₹ 0.00 & for BSE ₹ 20.70 as on Jun 30 2026 10:15 AM.

    What is the 52 Week High and Low of Rekvina Labs Ltd?

    Answer Field

    The 52 Week High and Low of Rekvina Labs Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 46.65 and ₹ 6.75.

    What is 1 year return for Rekvina Labs Ltd?

    Answer Field

    The 1 year returns on the stock has been 0.00%.

    What is the P/E Ratio of Rekvina Labs Ltd Share?

    Answer Field

    As on Jun 30 2026 10:15 AM the price-to-earnings (PE) ratio for Rekvina Labs Ltd share is -83.33.

    What is the PB ratio of Rekvina Labs Ltd Share?

    Answer Field

    As on Jun 30 2026 10:15 AM, the price-to-book (PB) ratio for Rekvina Labs Ltd share is -2.03.

    How to Buy Rekvina Labs Ltd Share?

    Answer Field

    You can trade in Rekvina Labs Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Rekvina Labs Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Rekvina Labs Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Rekvina Labs Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |